| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/06/1999 | EP0946590A2 Dihydroxypropyl cysteine peptide and agent containing this peptide |
| 10/06/1999 | EP0946205A2 Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them |
| 10/06/1999 | EP0946200A1 Immunization of infants |
| 10/06/1999 | EP0946196A1 Method for treating symptoms of diabetes |
| 10/06/1999 | EP0946195A1 Pharmaceutical products containing protein-tyrosine kinase inhibitors and anti-cd4 antibodies |
| 10/06/1999 | EP0946194A1 Vaccine composition containing as additive a sympathomimetic compound |
| 10/06/1999 | EP0946193A1 Stabilizers for lyophilized vaccines |
| 10/06/1999 | EP0946188A1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| 10/06/1999 | EP0946185A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND |
| 10/06/1999 | EP0601108B1 Multideterminant peptide antigens that stimulate helper t lymphocyte response to hiv in a range of human subjects |
| 10/06/1999 | EP0517815B1 AN IgG-1 HUMAN MONOCLONAL ANTIBODY REACTIVE WITH AN HIV-1 GLYCOPROTEIN AND METHOD OF USE |
| 10/06/1999 | CN1230893A Assembly-deficient herpesvirus vaccine |
| 10/06/1999 | CN1230549A Escape mutant of surface antigen of hepatitis B virus |
| 10/06/1999 | CN1045391C Oral delivery system |
| 10/05/1999 | US5962666 Polynucleotide or its complement which codes for enzyme involved in bacterial protein synthesis; for diagnosis and treatment of chlamydia infections such as urogenital disorders and vision defects; bactericides |
| 10/05/1999 | US5962644 Porcine CD34 |
| 10/05/1999 | US5962635 Therapeutic compounds |
| 10/05/1999 | US5962430 Analog of Haemophilus Hin47 with reduced protease activity |
| 10/05/1999 | US5962428 Compositions and methods for delivery of genetic material |
| 10/05/1999 | US5962411 Human growth hormone variants and methods of administering same |
| 10/05/1999 | US5962320 Engineered antigen presenting cells and methods for their use |
| 10/05/1999 | US5962318 Cytotoxic T lymphocyte-mediated immunotherapy |
| 10/05/1999 | US5962303 The invention relates to polynucleotides and polypeptides of bacterial ?topoisomerase iii.? |
| 10/05/1999 | US5962300 Polynucleotide which encodes a polypeptide tumor suppressor; for diagnosis, prevention, and treatment of cancer, eczema, psoriasis, psoriasis, scleroderma, dermatitis, skin atrophy, and other skin disorders; anticarcinogenic agents |
| 10/05/1999 | US5962298 Influenza vaccine |
| 10/05/1999 | US5962295 This invention relates to newly identified polynucleotides and polypeptides, and their production and uses, as well as their variants, agonists and antagonists, and their uses. |
| 10/05/1999 | US5962289 Polysaccharide binding fusion proteins and conjugates |
| 10/05/1999 | US5962269 Methods for producing antibodies which specifically bind to interleukin-9 receptor |
| 10/05/1999 | US5962259 Response regulator polynucleotides |
| 10/05/1999 | US5962257 Flea aminopeptidase nucleic acid molecules |
| 10/05/1999 | US5962240 Mycobacterium proteins and applications |
| 10/05/1999 | US5962230 Diagnosis and treatment of glaucoma |
| 10/05/1999 | US5962224 Isolated DNA encoding p62 polypeptides and uses therefor |
| 10/05/1999 | US5962217 MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, and biopolymer constituents thereof |
| 10/05/1999 | US5961985 Vaccine and serum for endotoxin associated disease immunization and treatment, detoxified endotoxin, and bacterial mutant |
| 10/05/1999 | US5961983 Stable pura vectors and uses therefor |
| 10/05/1999 | US5961982 Recombinant herpesvirus of turkeys and uses thereof |
| 10/05/1999 | US5961979 Complex of a mammalian stress protein noncovalently associated with a peptide that is present in a eukaryotic cell infected with said pathogen but not present in said cell when said cell is not infected with said pathogen |
| 10/05/1999 | US5961978 Therapeutically useful peptides and peptide fragments |
| 10/05/1999 | US5961977 Orally administering an autoantigen |
| 10/05/1999 | US5961975 Type I surface antigen associated with staphylococcus epidermidis |
| 10/05/1999 | US5961973 Binding agent which specifically binds a surface component of a pathogen, for instance the gp120 viral coat protein of the human immunodeficiency virus, and a catalytic moiety |
| 10/05/1999 | US5961972 Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity |
| 10/05/1999 | US5961970 Submicron emulsions as vaccine adjuvants |
| 10/05/1999 | US5961969 Enhancing natural killer cell cytotoxicity. |
| 10/05/1999 | US5961955 Radioprotectant for peptides labeled with radioisotope |
| 10/05/1999 | CA2004646C Protease, reverse transcriptase and endonuclease of retrovirus, and method for producing these enzymes |
| 10/05/1999 | CA1340776C Multispecific antigenic proteins |
| 09/30/1999 | WO1999049316A2 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 09/30/1999 | WO1999049067A1 Nucleic acid transfer vectors, compositions containing same and uses |
| 09/30/1999 | WO1999049055A1 Human casb12 polypeptide, a serine protease |
| 09/30/1999 | WO1999049054A1 Diagnostics and vaccines for mycobacterial infections of animals and humans |
| 09/30/1999 | WO1999049049A1 Streptococcus sag-a, a structural protein associated with sls activity |
| 09/30/1999 | WO1999049048A1 Identification genes and gene products involved in cytoadherance of plasmodium infected erythrocytes |
| 09/30/1999 | WO1999049045A2 Recombinant major allergen of the pollen of artemisia vulgaris (mugwort) |
| 09/30/1999 | WO1999049039A2 GFRα3 AND ITS USES |
| 09/30/1999 | WO1999049034A1 Breast cancer antigen |
| 09/30/1999 | WO1999049033A1 Casb414: antigen overexpressed in several tumors |
| 09/30/1999 | WO1999049030A1 Compounds related to pap-1 |
| 09/30/1999 | WO1999049026A1 Bacteria attenuated by a non-reverting mutation in each of the aroc, ompf and ompc genes, useful as vaccines |
| 09/30/1999 | WO1999049017A2 Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b |
| 09/30/1999 | WO1999048925A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 09/30/1999 | WO1999048919A1 H.pylori antigen and its use |
| 09/30/1999 | WO1999048917A2 Formulation having a papilloma virus-specific protein, and the production and use thereof |
| 09/30/1999 | WO1999048527A1 Apo-2 ligand-anti-her-2 antibody synergism |
| 09/30/1999 | WO1999048526A1 METHOD OF RENDERING A HUMAN IMMUNODEFICIENCY VIRUS POPULATION REPLICATION INCOMPETENT $i(IN VIVO) |
| 09/30/1999 | WO1999048525A1 Hib/dtpa vaccine composition and methods of preparation |
| 09/30/1999 | WO1999048524A1 Use of cytokines and mitogens to inhibit graft versus host disease |
| 09/30/1999 | WO1999048523A2 Antagonists of the inflammatory mediator oncostatin m (osm) |
| 09/30/1999 | WO1999048521A1 Sciellin and uses thereof |
| 09/30/1999 | WO1999048518A2 Medicament for preventing or treating papilloma virus-specific tumors |
| 09/30/1999 | WO1999048515A1 Trimeric antigenic o-linked glycopeptide conjugates, methods of preparation and uses thereof |
| 09/30/1999 | WO1999048508A1 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms |
| 09/30/1999 | WO1999048495A1 Benzoates derivatives for inhibiting angiogenesis |
| 09/30/1999 | WO1999048348A1 Helicobacter pylori derived factor which inhibits ena-78 secretion |
| 09/30/1999 | WO1999042478A3 LEPTOSPIRAL OUTER MEMBRANE PROTEIN, LipL32 |
| 09/30/1999 | WO1999041383A8 Antigen library immunization |
| 09/30/1999 | WO1999038532A3 Methods for the prevention and treatment of fibrosis and sclerosis |
| 09/30/1999 | WO1999037788A3 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 09/30/1999 | WO1999037777A3 Differentiation-associated sequences and methods of use therefor |
| 09/30/1999 | WO1999033853A3 Carbohydrates, useful in solid delivery systems |
| 09/30/1999 | DE19906034A1 High-purity squalane useful in cosmetic and pharmaceutical products, as vaccine adjuvant, for coating condoms and hypodermic needles, etc. |
| 09/30/1999 | CA2325585A1 Inflammatory mediator antagonists |
| 09/30/1999 | CA2325436A1 Vaccine composition |
| 09/30/1999 | CA2324616A1 Trimeric antigenic o-linked glycopeptide conjugates, methods of preparation and uses thereof |
| 09/30/1999 | CA2324494A1 Apo-2 ligand-anti-her-2 antibody synergism |
| 09/30/1999 | CA2324347A1 Benzoates derivatives for inhibiting angiogenesis |
| 09/30/1999 | CA2324340A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 09/30/1999 | CA2323927A1 Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b |
| 09/30/1999 | CA2323831A1 Nucleic acid transfer vectors, compositions containing same and uses |
| 09/30/1999 | CA2323760A1 Human casb12 polypeptide, a serine protease |
| 09/30/1999 | CA2323601A1 Casb414: antigen overexpressed in several tumors |
| 09/30/1999 | CA2323573A1 Medicament for preventing or treating papilloma virus-specific tumors |
| 09/30/1999 | CA2323526A1 Formulation having a papilloma virus-specific protein, and the production and use thereof |
| 09/30/1999 | CA2323501A1 Compounds related to pap-1 |
| 09/30/1999 | CA2290653A1 Streptococcus sag-a, a structural protein associated with sls activity |
| 09/29/1999 | EP0945512A2 Novel serine proteases |
| 09/29/1999 | EP0945465A1 Antagonistic monoclonal antibodies to human CD40 |
| 09/29/1999 | EP0945464A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 09/29/1999 | EP0945461A1 Lipopeptides inducing T-cyxtotoxic lymphocytes and their use as vaccines |